Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Voon, Valerie ^a   Schoerling, Andrea ^b   Wenzel, Sascha ^b   Ekanayake, Vindhya ^c   Reiff, Julia ^d   Trenkwalder, Claudia ^b   Sixel Döring, Friederike ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Paracelsus Elena Hospital   (Germany)

^c PURDUE UNIVERSITY   (United States)

^d DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Dopamine agonist; Gambling; Impulse control disorders; Levodopa; Restless legs syndrome

Indexed keywords

CABERGOLINE; LEVODOPA; LISURIDE; PRAMIPEXOLE; ROPINIROLE; DOPAMINE RECEPTOR STIMULATING AGENT;

ARTICLE; BINGE EATING DISORDER; COHORT ANALYSIS; COMPULSION; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; GERMANY; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL GAMBLING; PREVALENCE; PSYCHOLOGIC TEST; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SHOPPING; AGE; AGED; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; STATISTICS;

AGE FACTORS; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOPAMINE AGONISTS; FEMALE; GERMANY; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PREVALENCE; RESTLESS LEGS SYNDROME; RISK FACTORS; SEX FACTORS;

EID: 80053378685     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-117     Document Type: Article

References (36)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119. 10.1016/S1389-9457(03)00010-8, 14592341.
2. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005, 4:465-475. 10.1016/S1474-4422(05)70139-3, 16033689.
3. Paulus W, Schomburg ED. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?. Sleep Med Rev 2006, 10:185-196. 10.1016/j.smrv.2006.01.004, 16762808.
4. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord 2007,
5. Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008, 23:2267-2302. 10.1002/mds.22254, 18925578.
6. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006, 67:1254-1257. 10.1212/01.wnl.0000238503.20816.13, 16957130.
7. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006, 21:2068-2072. 10.1002/mds.21072, 17044068.
8. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006, 63:969-973. 10.1001/archneur.63.7.969, 1761054, 16831966.
9. Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, Grosset DG. Problematic gambling on dopamine agonists: Not such a rarity. Mov Disord 2006, 21:2206-2208. 10.1002/mds.21110, 17013907.
10. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595. 10.1001/archneurol.2010.65, 20457959.
11. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006, 21:524-529. 10.1002/mds.20757, 16261618.
12. Miyasaki JM, Al Hassan K, Lang AE, Voon V. Punding prevalence in Parkinson's disease. Mov Disord 2007, 22:1179-1181. 10.1002/mds.21296, 17230464.
13. Lawrence AJ, Blackwell AD, Barker RA, Spagnolo F, Clark L, Aitken MR, Sahakian BJ. Predictors of punding in Parkinson's disease: results from a questionnaire survey. Mov Disord 2007, 22:2339-2345. 10.1002/mds.21702, 17914729.
14. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004, 19:397-405. 10.1002/mds.20045, 15077237.
15. Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005, 65:1570-1574. 10.1212/01.wnl.0000184487.72289.f0, 16301483.
16. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000, 68:423-428. 10.1136/jnnp.68.4.423, 1736875, 10727476.
17. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007, 64:212-216. 10.1001/archneur.64.2.212, 17296836.
18. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006, 67:1258-1261. 10.1212/01.wnl.0000238401.76928.45, 17030761.
19. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987, 144:1184-1188.
20. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007, 64:1089-1096. 10.1001/archneur.64.8.1089, 17698698.
21. . American Psychiatric Association, American Psychiatric Association. Task Force on DSM-IV Diagnostic and statistical manual of mental disorders: DSM-IV 1994, Washington, DC: American Psychiatric Association, 4, American Psychiatric Association, American Psychiatric Association. Task Force on DSM-IV.
22. McElroy SL, Keck PE, Pope HG, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. J Clin Psychiatry 1994, 55:242-248.
23. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. Jama 2002, 287:455-463. 10.1001/jama.287.4.455, 11798367.
24. Ondo WG, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008, 14:28-32. 10.1016/j.parkreldis.2007.05.006, 17702628.
25. Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007, 30:249-255. 10.1097/wnf.0b013e31804c780e, 17909302.
26. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010, 33:81-87. 2802252, 20120624.
27. Pourcher E, Remillard S, Cohen H. Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci 2010, 290:52-56. 10.1016/j.jns.2009.11.010, 19969309.
28. Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 2008, 23:411-415. 10.1002/mds.21872, 18067187.
29. Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, Zecchinelli AL, Pezzoli G, Antonini A. Cognitive status of patients with Parkinson's disease and pathological gambling. J Neurol 2010, 257:247-252.
30. Pezzella FR, Colosimo C, Vanacore N, Di Rezze S, Chianese M, Fabbrini G, Meco G. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Mov Disord 2005, 20:77-81. 10.1002/mds.20288, 15390130.
31. Hudson JI, Hiripi E, Pope HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007, 61:348-358. 10.1016/j.biopsych.2006.03.040, 1892232, 16815322.
32. Koran LM, Faber RJ, Aboujaoude E, Large MD, Serpe RT. Estimated prevalence of compulsive buying behavior in the United States. Am J Psychiatry 2006, 163:1806-1812. 10.1176/appi.ajp.163.10.1806, 17012693.
33. Preti A, Girolamo G, Vilagut G, Alonso J, Graaf R, Bruffaerts R, Demyttenaere K, Pinto-Meza A, Haro JM, Morosini P. The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res 2009, 43:1125-1132. 10.1016/j.jpsychires.2009.04.003, 19427647.
34. Potenza MN, Kosten TR, Rounsaville BJ. Pathological gambling. JAMA 2001, 286:141-144. 10.1001/jama.286.2.141, 11448261.
35. Buhringer G, Kraus L, Sonntag D, Pfeiffer-Gerschel T, Steiner S. Pathological gambling in Germany: Gambling and population based risks. SUCHT 2007, 53:296-308.
36. Antonini A, Cilia R. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Drug Saf 2009, 32:475-488. 10.2165/00002018-200932060-00004, 19459715.